Michael H. Mulroy - Nov 22, 2024 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Daniel Collins, as Attorney-in-Fact
Stock symbol
LCTX
Transactions as of
Nov 22, 2024
Transactions value $
$22,640
Form type
4
Date filed
11/25/2024, 04:30 PM
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares Purchase $22.6K +40K +15.47% $0.57 299K Nov 22, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.